ADRA2A and schizophrenia: Division of schizophrenia subjects by presence or absence of blood antipsychotics, revealed that H3K27me3 at ADRA2A promoter was significantly increased in AP-treated schizophrenia subjects (Δ = +159% vs matched controls, p = 0.006, Fig. 3B).